Cargando…

The Role of Thyrotropin-Releasing Hormone Stimulation Test in Management of Hyperthyrotropinemia in Infants

OBJECTIVE: Hyperthyrotropinemia, which can be either a permanent or a transient state, is an asymptomatic condition and there is a controversy in management and long-term consequences. The aim of this study was to evaluate the results of thyrotropin-releasing hormone (TRH) test in infants with hyper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altıncık, Ayça, Demir, Korcan, Çatlı, Gönül, Abacı, Ayhan, Böber, Ece
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677556/ https://www.ncbi.nlm.nih.gov/pubmed/26831555 http://dx.doi.org/10.4274/jcrpe.1985

Ejemplares similares

Acceleration of Puberty During Growth Hormone Therapy in a Child with Septo-Optic Dysplasia
por: Çatlı, Gönül, et al.
Publicado: (2014)

The Role of Initial Clinical and Laboratory Findingsin Infants With Hyperthyrotropinemia to PredictTransient or Permanent Hypothyroidism
por: Ünüvar, Tolga, et al.
Publicado: (2013)

Fine−Needle Aspiration Biopsy in the Diagnosis and Follow−Up of Thyroid Nodules in Childhood
por: Altıncık, Ayça, et al.
Publicado: (2010)

Growth of Children with Type 1 Diabetes Mellitus
por: Demir, Korcan, et al.
Publicado: (2010)

Effect of gonadotropin-releasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty
por: Anık, Ahmet, et al.
Publicado: (2015)

Epidemiology, Classification and Management of Undescended Testes: Does Medication Have Value in its Treatment?
por: Abacı, Ayhan, et al.
Publicado: (2013)

46,XX Male Disorder of Sexual Development: A Case Report
por: Anık, Ahmet, et al.
Publicado: (2013)

Acute Vitamin D Intoxication Possibly Due to Faulty Production of a Multivitamin Preparation
por: Anık, Ahmet, et al.
Publicado: (2013)

The relationship of carotid intima-media thickness with anthropometric and metabolic parameters in patients with classic congenital adrenal hyperplasia
por: TUHAN, Hale, et al.
Publicado: (2021)

Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
por: ERBAŞ, İbrahim Mert, et al.
Publicado: (2021)

The Effect of L-Thyroxine Treatment on Hypothyroid Symptom Scores and Lipid Profile in Children with Subclinical Hypothyroidism
por: Çatlı, Gönül, et al.
Publicado: (2014)

Evaluation of Thyroid Function Tests in Children with Chronic Liver Diseases
por: Ön, Ş. Şebnem, et al.
Publicado: (2020)

The Missense Alteration A5T of the Thyroid Peroxidase Gene is Pathogenic and Associated with Mild Congenital Hypothyroidism
por: Cangül, Hakan, et al.
Publicado: (2015)

Recovery of Central Fever after GH Therapy in a Patient with GH Deficiency Secondary to Posttraumatic Brain Injury
por: Ünver Tuhan, Hale, et al.
Publicado: (2015)

A Mutation in INSR in a Child Presenting with Severe Acanthosis Nigricans
por: Tuhan, Hale, et al.
Publicado: (2017)

Has the Frequency of Precocious Puberty and Rapidly Progressive Early Puberty Increased in Girls During the COVID-19 Pandemic?
por: Yüksek Acinikli, Kübra, et al.
Publicado: (2022)

The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity
por: Küme, Tuncay, et al.
Publicado: (2017)

Growth Hormone Dosing Estimations Based on Body Weight Versus Body Surface Area
por: Besci, Özge, et al.
Publicado: (2023)

Low Complement C1q/TNF-related Protein-13 Levels are Associated with Childhood Obesity But not Binge Eating Disorder
por: Erbaş, İbrahim Mert, et al.
Publicado: (2022)

A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?
por: Besci, Özge, et al.
Publicado: (2022)

Factors associated with moderate neonatal hyperthyrotropinemia
por: Cortés-Castell, Ernesto, et al.
Publicado: (2019)

Effect of early or late blood sampling on thyrotropin releasing hormone stimulation test results in horses
por: Thane, Kristen, et al.
Publicado: (2022)

Adverse Events Associated with COVID-19 Vaccination in Adolescents with Endocrinological Disorders: A Cross-Sectional Study
por: Erbaş, İbrahim Mert, et al.
Publicado: (2023)

Unexplained Hyperthyrotropinemia: A Biochemical and Clinical Challenge
por: Croce, Laura, et al.
Publicado: (2023)

Effect of thyrotropin‐releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol
por: Hodge, Elizabeth, et al.
Publicado: (2019)

Repeatability of a thyrotropin‐releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses
por: Kam, Yan Ning, et al.
Publicado: (2021)

GATA2 Mediates Thyrotropin-Releasing Hormone-Induced Transcriptional Activation of the Thyrotropin β Gene
por: Ohba, Kenji, et al.
Publicado: (2011)

Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses
por: Hinrichsen, Sophia L., et al.
Publicado: (2022)

Molecular basis for the activation of thyrotropin-releasing hormone receptor
por: Ji, Su-Yu, et al.
Publicado: (2022)

Update on Neonatal Isolated Hyperthyrotropinemia: A Systematic Review
por: Chiesa, Ana E., et al.
Publicado: (2021)

Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder
por: Besci, Özge, et al.
Publicado: (2022)

Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3
por: Acar, Sezer, et al.
Publicado: (2018)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

Desensitization, Trafficking, and Resensitization of the Pituitary Thyrotropin-Releasing Hormone Receptor
por: Hinkle, Patricia M., et al.
Publicado: (2012)

Pituitary response to thyrotropin releasing hormone in children with overweight and obesity
por: Rijks, Jesse, et al.
Publicado: (2016)

The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?
por: Charli, Jean-Louis, et al.
Publicado: (2020)

Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries
por: Rodríguez-Rodríguez, Adair, et al.
Publicado: (2019)

Origin of thyrotropin-releasing hormone neurons that innervate the tuberomammillary nuclei
por: Sánchez-Jaramillo, Edith, et al.
Publicado: (2022)

SUN-465 Thyrotropin-Releasing Hormone-Degrading Ectoenzyme Controls Thyrotropin Secretion and Body Weight in Male Rodents
por: Charli, Jean-Louis, et al.
Publicado: (2019)

Transient Hyperthyrotropinemia in Outpatient Children with Acute Infections of the Respiratory System
por: Adamczewska, Katarzyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ofgv1lukettq003ifrmrdqck6g